Intervention 1: Intervention group: The systemic treatment regimen will be adjusted based on the severity of the disease, as follows:- Grade II: Oral prednisolone with a starting dose of 30-20 mg/day,

3 trials

Sponsors

Shiraz University of Medical Sciences

Conditions

Granulomatous Mastitis. Inflammatory disorders of breastIdiopathic Granulomatous Mastitis. Inflammatory disorders of breast

Phase 2

Topical steroid in Managing Skin Involvement of Patients with Idiopathic Granulomatous Mastitis.

Active, not recruitingIRCT20230822059222N1

Shiraz University of Medical SciencesIdiopathic Granulomatous Mastitis. Inflammatory disorders of breast

Start: 2023-10-22Target: 40Updated: 2023-10-16

Topical Tacrolimus in Managing Skin Involvement of Patients with Idiopathic Granulomatous Mastitis.

Active, not recruitingIRCT20230822059222N2

Shiraz University of Medical SciencesIdiopathic Granulomatous Mastitis. Inflammatory disorders of breast

Start: 2024-04-02Target: 36Updated: 2024-05-27

Local injection of methylprednisolone in the treatment of patients with idiopathic granulomatous mastitis.

Active, not recruitingIRCT20200608047694N2

Shiraz University of Medical SciencesGranulomatous Mastitis. Inflammatory disorders of breast

Start: 2024-11-21Target: 60Updated: 2025-12-08